SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-117612
Filing Date
2020-10-23
Accepted
2020-10-23 13:21:57
Documents
1
Period of Report
2020-10-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 tm2034126-4_3.html 3  
1 FORM 3 tm2034126-4_3.xml 3 2995
  Complete submission text file 0001104659-20-117612.txt   4481
Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 (212) 710-5220
Eucrates LLC (Reporting) CIK: 0001822897 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-39650 | Film No.: 201257055

Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 (212) 710-5220
Eucrates Biomedical Acquisition Corp. (Issuer) CIK: 0001822929 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
SIC: 6770 Blank Checks